Tirzepatide

Tirzepatide (Mounjaro® / Zepbound®)

Tirzepatide is a once-weekly injectable medication shown to significantly enhance weight loss and improve long-term weight management in adults with obesity or chronic weight-related conditions.

Mechanism of Action

Tirzepatide is a synthetic polypeptide and a dual agonist of two incretin receptors:

These gut-derived hormones help regulate:

Insulin secretion to improve glycemic control

Reduction of hyperglycemia

Appetite suppression and increased satiety

Together, these actions support substantial and sustained weight loss.

Administration

Tirzepatide is administered as a once-weekly subcutaneous injection in the clinic.
Professional administration ensures safe dosing, correct injection technique, and minimizes risks such as injection-site complications.
Clients receive weekly weigh-ins using our medical-grade bioelectrical impedance analysis (BIA) scale. This provides detailed metrics, including:

This allows precise monitoring of true fat loss versus muscle gain throughout treatment.

Connect With Us

Contact